✦ LIBER ✦

Corticosteroids and rituximab as adjunctive treatments for thrombotic thrombocytopenic purpura

✍ Scribed by James N. George

Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 708 KB
Volume: 87
Category: Article
ISSN: 0361-8609
DOI: 10.1002/ajh.23126

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Rituximab for treatment of refractory/re

Rituximab for treatment of refractory/relapsing thrombotic thrombocytopenic purpura (TTP)

✍ Afaq Ahmad; Anita Aggarwal; Daya Sharma; Harish P. Dave; Virginia Kinsella; Marg 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB 👁 2 views

## Abstract Plasma exchange is the standard treatment for thrombotic thrombocytopenic purpura (TTP). For patients refractory to plasma exchange, treatment options are limited and often unsuccessful. The platelet thrombi that form in acquired TTP are believed to result from the presence of procoagul

Vincristine as salvage treatment for ref

Vincristine as salvage treatment for refractory thrombotic thrombocytopenic purpura

✍ F. Ferrara; C. Copia; M. Annunziata; A. Spasiano; C. Di Grazia; S. Palmieri; L. 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 65 KB

Rituximab for the treatment of refractor

Rituximab for the treatment of refractory idiopathic thrombocytopenic purpura (ITP) and thrombotic thrombocytopenic purpura (TTP): Report of three cases

✍ Lydia Koulova; Doru Alexandrescu; Janice P. Dutcher; Kevin P. O'Boyle; Saji Eape 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 162 KB 👁 2 views

Three patients (one with idiopathic thrombocytopenic purpura [ITP] and two with thrombotic thrombocytopenic purpura [TTP]) were treated with rituximab (anti-CD20 chimeric antibody) at a dose of 325 mg/m 2 administered weekly after they failed standard therapies. The patient with ITP who did not resp

Successful repeat therapy with rituximab

Successful repeat therapy with rituximab for relapsed thrombotic thrombocytopenic purpura

✍ Wilmar Patino; Ravindra Sarode 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 141 KB

## Abstract Thrombotic thrombocytopenic purpura (TTP) is a life‐threatening disease that is treated successfully with therapeutic plasma exchange (TPE) and often with corticosteroids; however, almost one third of TTP patients have treatment failures that require either long‐term TPEs or other adjun

Vincristine as treatment for recurrent e

Vincristine as treatment for recurrent episodes of thrombotic thrombocytopenic purpura

✍ F. Ferrara; M. Annunziata; F. Pollio; S. Palmieri; C. Copia; G. Mele; B. Pocali; 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 40 KB

Treatment of thrombotic thrombocytopenic

Treatment of thrombotic thrombocytopenic purpura with plasma exchange, antiplatelet agents, corticosteroid, and plasma infusion: Mayo clinic experience

✍ Robert L. Breckenridge Jr.; Lawrence A. Solberg; Alvaro A. Pineda; Robert M. Pet 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 665 KB

## Abstract Ten patients with thrombocytopenia (TTP) were treated recently in our institution with plasma exchange (PE), steroids, and antiplatelet drugs. Additionally, fresh frozen plasma (FFP) was administered to nine patients, with folic acid given to eight patients. After 13 to 25 months of fo